3632 results for «557»

Filter By

3632 results

Spontaneous coronary artery dissection management with intracoronary imaging

22 May 2026 – From EuroPCR 2026

Explore the nuanced management of spontaneous coronary artery dissection (SCAD) with a focus on intracoronary imaging. This session examines diagnostic challenges, the limited role of coronary CT angiography, and strategies for managing occlusive SCAD cases, highlighting the evolving understanding of this complex condition.

Challenges in treating tricuspid regurgitation

22 May 2026 – From EuroPCR 2026

This session addresses the complexities of treating tricuspid regurgitation, offering insights into tailored treatment options and complication management. Through detailed case studies from China and Germany, it highlights practical approaches and bailout strategies for tricuspid valve interventions.

Updates in tricuspid TEER

21 May 2026 – From EuroPCR 2026

This session offers comprehensive updates on transcatheter edge-to-edge repair (TEER) for tricuspid valve disease. It reviews meta-analyses on outcomes in patients with cardiac implantable electronic device leads, long-term trial results, echocardiographic and clinical outcomes, right ventricular mechanics, risk scoring, and the impact of renal function and...

How to treat aortic regurgitation

22 May 2026 – From EuroPCR 2026

Explore cutting-edge transcatheter approaches for aortic regurgitation, including first-in-human ATLAS technique, management in LVAD patients, and off-label Myval use. This session reviews clinical challenges and innovative solutions in aortic valve interventions, offering valuable insights from complex procedural experiences.

Best structural complications

22 May 2026 – From EuroPCR 2026

This session highlights the management of complex structural complications encountered in high-risk valve interventions. It covers troubleshooting in mitral annular calcification, challenges with the BASILICA technique, creative bailouts for valve embolisation, and considerations in leaflet management during aortic stenosis procedures.

Best structural complications

Left main PCI: predictions of risk and long-term clinical outcome

22 May 2026 – From EuroPCR 2026

This session focuses on risk prediction and long-term outcomes following left main percutaneous coronary intervention (PCI). It covers biomarkers like NT-proBNP, hemodynamic predictors, and the impact of comorbidities such as diabetes and chronic kidney disease on patient prognosis over a ten-year follow-up.

Right-sided interventions and impact on the right heart

22 May 2026 – From EuroPCR 2026

This session examines right-sided cardiac interventions and their impact on right heart function. Topics include prognostic implications of right ventricular wall tension, novel metrics for RV-PA coupling, clinical effects of severe tricuspid regurgitation, and strategies for transcatheter pulmonary valve replacement in complex right ventricular outflow tract...

LAA closure and pulmonary embolism hotline

22 May 2026 – From EuroPCR 2026

Focusing on left atrial appendage (LAA) closure and pulmonary embolism management, this session reviews device-related thrombus, implant healing with novel coatings, and compares mechanical thrombectomy to catheter-directed thrombolysis. It also discusses the prognostic impact of hemodynamic data post-thrombectomy to inform clinical outcomes.

LAA closure and pulmonary embolism hotline

Technical decision-making for CTO PCI strategy

22 May 2026 – From EuroPCR 2026

This session focuses on technical decision-making for chronic total occlusion PCI strategy. It presents diverse approaches to right coronary CTOs, complex management involving double rendezvous techniques, subintimal strategies, and innovative single-injection methods, demonstrating the evolving frontiers in CTO intervention.

Taking on the tough stuff: TAVI in complex anatomies

21 May 2026 – From EuroPCR 2026

Focused on the challenges of transcatheter aortic valve implantation (TAVI) in complex anatomies, this session addresses optimal strategies for treating bicuspid aortic valve stenosis, managing small annuli and low coronary ostia, and approaches to degenerated surgical valves including bioprosthetic fracture techniques. Case-based discussions elucidate practical solutions...

Taking on the tough stuff: TAVI in complex anatomies

Challenging PCI on bifurcation lesions

22 May 2026 – From EuroPCR 2026

Addressing the complexities of PCI in bifurcation lesions, this session highlights novel techniques such as the TAP and modified mini-crush methods, alongside strategies for managing challenging coronary anatomy. Validation of novel approaches like POT-side DCB-POT for left main bifurcations is also featured.

DCB: what we know and what we do not know

22 May 2026 – From EuroPCR 2026

This session provides a detailed update on drug-coated balloons (DCB) in interventional cardiology, covering the latest clinical data and trials. It identifies scenarios where DCB use is most effective and offers guidance on optimizing procedural techniques to enhance clinical outcomes.

DCB: what we know and what we do not know

Unusual clinical cases: thinking beyond the routine

22 May 2026 – From EuroPCR 2026

This session presents unusual and challenging clinical cases that extend beyond routine interventional cardiology. From optimised in-stent restenosis treatment to rare anatomical anomalies and complex thrombus management, it offers valuable lessons in creative problem-solving and advanced intervention techniques.

New evidence for coronary revascularisation

21 May 2026 – From EuroPCR 2026

This session highlights new evidence in coronary revascularisation, including the role of CT-derived virtual stenting for procedural optimization, left ventricular unloading during complex PCI, long-term outcomes of FFR-guided PCI versus medical therapy, Impella CP support in high-risk PCI, and comparative results of PCI versus CABG in...

New evidence for coronary revascularisation

Management of uncommon TAVI complications

21 May 2026 – From EuroPCR 2026

This session delves into the management of uncommon but critical complications arising from Transcatheter Aortic Valve Implantation (TAVI). Through detailed case studies from Italy, Lebanon, and Turkey, it highlights real-time decision-making strategies for life-threatening scenarios including left ventricular outflow tract obstruction, acute aortic dissection, and complex...

TAVI in bicuspid - Planning to performance

22 May 2026 – From EuroPCR 2026

Dedicated to transcatheter aortic valve implantation (TAVI) in bicuspid aortic valves, this session examines anatomical assessment, sizing methods, and clinical outcomes. It includes meta-analyses and registry insights, addressing challenges such as stent deformation and leaflet modification to guide optimal TAVI performance in this distinct patient population.

Atypical NSTEMI culprit lesions

22 May 2026 – From EuroPCR 2026

Focusing on atypical NSTEMI culprit lesions, this session examines rare presentations such as calcific emboli, coronary anomalies, and unusual routes to revascularisation. It provides clinical insights into diagnosing and managing uncommon acute coronary syndromes effectively.

Left main complications - Part 3

21 May 2026 – From EuroPCR 2026

This session reviews complex complications encountered in left main coronary interventions. It covers causes and management of acute left main occlusion, critical stenosis of coronary buttons, retrieval techniques for ostial stents, and strategies for managing challenging PCI scenarios that may precipitate or resolve catastrophic events.

Left main complications - Part 3

Multivessel disease or left main disease

22 May 2026 – From EuroPCR 2026

This session explores revascularisation strategies for patients with multivessel or left main coronary artery disease. It emphasizes the role of intravascular physiology and imaging in guiding treatment decisions and highlights procedural factors that contribute to improved long-term clinical outcomes, supported by complex case discussions.

Clinical decision making for CTO PCI strategy

22 May 2026 – From EuroPCR 2026

This session explores clinical decision-making in CTO PCI strategy through complex scenarios including multivessel CTO in ischemic cardiomyopathy, high-risk NSTEMI post-vein graft failure, and challenges in elderly patients. It emphasizes strategic planning and individualized approaches to optimize outcomes.

Didn’t find what you were looking for?